| Authors: |
Atmar RL; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Ettayebi K; Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Neill FH; Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Braun RP; Icosavax, Seattle, Washington, USA., Sherwood J; Takeda Pharmaceuticals International, Zurich, Switzerland (former affiliation)., Ramani S; Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Estes MK; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA. |